Rocket Pharmaceuticals Statistics

Total Valuation

RCKT has a market cap or net worth of $1.80 billion. The enterprise value is $1.49 billion.

Market Cap	1.80B
Enterprise Value	1.49B

Important Dates

The next estimated earnings date is Thursday, August 8, 2024, before market open.

Earnings Date	Aug 8, 2024
Ex-Dividend Date	n/a

Share Statistics

RCKT has 90.78 million shares outstanding. The number of shares has increased by 17.74% in one year.

Shares Outstanding	90.78M
Shares Change (YoY)	+17.74%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	3.44%
Owned by Institutions (%)	106.20%
Float	70.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.07
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.47, with a Debt / Equity ratio of 0.06.

Current Ratio	10.47
Quick Ratio	n/a
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-131.76

Financial Efficiency

Return on equity (ROE) is -53.10% and return on invested capital (ROIC) is -56.66%.

Return on Equity (ROE)	-53.10%
Return on Assets (ROA)	-46.90%
Return on Capital (ROIC)	-56.66%
Revenue Per Employee	n/a
Profits Per Employee	-$930,276
Employee Count	268
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -0.90% in the last 52 weeks. The beta is 1.07, so RCKT's price volatility has been similar to the market average.

Beta (5Y)	1.07
52-Week Price Change	-0.90%
50-Day Moving Average	22.35
200-Day Moving Average	24.23
Relative Strength Index (RSI)	37.18
Average Volume (20 Days)	1,088,418

Short Selling Information

The latest short interest is 9.26 million, so 10.20% of the outstanding shares have been sold short.

Short Interest	9.26M
Short Previous Month	9.41M
Short % of Shares Out	10.20%
Short % of Float	13.10%
Short Ratio (days to cover)	14.57

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-264.84M
Pretax Income	-249.31M
Net Income	-249.31M
EBITDA	-239.76M
EBIT	-247.44M
Earnings Per Share (EPS)	-$2.85

Full Income Statement

Balance Sheet

The company has $332.21 million in cash and $25.95 million in debt, giving a net cash position of $306.26 million or $3.37 per share.

Cash & Cash Equivalents	332.21M
Total Debt	25.95M
Net Cash	306.26M
Net Cash Per Share	$3.37
Equity (Book Value)	441.50M
Book Value Per Share	4.86
Working Capital	312.20M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$194.21 million and capital expenditures -$15.49 million, giving a free cash flow of -$209.70 million.

Operating Cash Flow	-194.21M
Capital Expenditures	-15.49M
Free Cash Flow	-209.70M
FCF Per Share	-$2.24

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RCKT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.74%
Shareholder Yield	-17.74%
Earnings Yield	-13.88%
FCF Yield	-11.68%

Dividend Details

Analyst Forecast

The average price target for RCKT is $53.56, which is 170.78% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$53.56
Price Target Difference	170.78%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 5, 2018. It was a reverse split with a ratio of 1:4.

Last Split Date	Jan 5, 2018
Split Type	Reverse
Split Ratio	1:4

Scores

Altman Z-Score	n/a
Piotroski F-Score	1